| Scenario 1 | Scenario 2 | Scenario 3 | Scale up |
---|---|---|---|---|
National implementing partner cost (PR) (% reduction of 2022 capital cost (activity cost) during startup and implementation) | Sub-national implementing partner cost (SR) (% reduction of 2022 capital cost (activity cost) during startup and implementation; and personnel salaries) | Local implementing partner costs (% reduction of 2022 capital cost (activity cost) during startup and implementation; and personnel salaries) | Reaching oral HIVST kits distribution target for HIV CBS (% of target) | |
2022 | Current state | Current state | Current state | Current state |
2023 | -20% | -20% | -20% | 50% |
2024 | -40% | -40% | -40% | 60% |
2025 | -50% | -50% | -50% | 70% |
2026 | -60% | -60% | -60% | 80% |
2027 | -80% | -80% | -80% | 90% |